NUMBER OF SHARES IN ELEKTA AS OF MARCH 31, 2009

NUMBER OF SHARES IN ELEKTA AS OF MARCH 31, 2009

Press Release 
Stockholm, Sweden, March 31, 2009


According to legislation, all publicly listed companies must - if the number of
shares has changed during the month - publish the total number of shares in the
company on the last trading day of the month.

During March, 951,300 B shares out of Elekta's treasury holding were cancelled,
in accordance with the decision by the Annual General Meeting on September 18,
2008.

The total number of shares in Elekta as of March 31, 2009, amounts to 92,124,563
divided between 3,562,500 A shares and 88,562,063 B shares.

One Series A share entitles the holder to 10 votes and one Series B share to one
vote.

After this cancellation, Elekta does not hold any own shares. 



For further information, please contact:

Lena Schattauer, Investor Relations, Elekta AB
Tel: +46 8 587 257 22, +46 70 595 51 00, e-mail: lena.schattauer@elekta.com   


About Elekta

Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated state of the art tools and treatment planning systems for
radiation therapy and radiosurgery, as well as workflow enhancing software
systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare providers
and patients, Elekta aims to improve, prolong and even save patient lives,
making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000
hospitals globally, and every day more than 100,000 patients receive diagnosis,
treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is
located in Stockholm, Sweden, and the company is listed on the Nordic Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com.